Overview
Lobbying Costs
750,000€
Financial year: Jan 2017 - Dec 2017
Lobbyists (Full time equivalent)
1.75 Fte (4)
Lobbyists with EP accreditation
2
High-level Commission meetings
18
Lobbying Costs over the years
-
Info
Eli Lilly and Company (Lilly)
EU Transparency Register
04657143399-39 First registered on 02 Apr 2010
Goals / Remit
Lilly is a leading innovative biopharmaceutical company that unites caring with discovery to make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Headquartered in the US, Lilly has approximately 40,660 employees worldwide with approximately 22,240 based outside the US. In 2017 global revenue was approx. $22.87 billion, of which c.23% were invested in R&D.
( https://investor.lilly.com/financials.cfm )
Elanco is the animal health business unit of Lilly. Elanco is an innovation-based company which makes life sciences work better for people by transforming animal protein production and companion animal care. Elanco operates in more than 70 countries worldwide, focusing on products for companion animal and food animal health, vaccines, parasiticides, enzymes, diagnostics and aquaculture.
Both are part of Lilly as a single legal entity.Main EU files targeted
Jobs and Growth; Science and Innovation; Public Health; Sustainable Healthcare; eHealth; Human and animal healthcare legislation; Intellectual Property; European Medicines Agency; Data Privacy, Clinical Trials Regulation; Health Technology Assessment including EUnetHTA; Transparency Directive; Falsified Medicines Directive; Trade including Trans-Atlantic, CETA and Brexit; Industrial policy; Competition; Taxation; Environment including REACH and PIE; Innovative Medicines Initiative; AMR; Horizon 2020; Biosimilars; Transparency Register; European Semester.
Address
Head Office
Lilly Corporate Centre
Indianapolis
Indianapolis 46285
UNITED STATESEU Office
Rue du Marquis 1
Brussels B-1000
BELGIUM -
People
Total lobbyists declared
4
Employment time Lobbyists 50% 3 25% 1 Lobbyists (Full time equivalent)
1.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 11 Apr 2018
Name Start date End Date Maurizio GUIDI 15 Dec 2023 13 Dec 2024 Ludovica FLORENZANO 04 Apr 2024 02 Oct 2024 Antonella ETTORRE 15 Dec 2023 13 Dec 2024 Fanny VERSPEELT 16 Feb 2024 14 Feb 2025 Aoife GALLAGHER 15 Dec 2023 13 Dec 2024 Doris SCHERNHAMMER 15 Dec 2023 13 Dec 2024 Mr Pierluca ARIETTI 16 Dec 2023 21 Mar 2024 Aoife GALLAGHER 25 Jan 2023 15 Dec 2023 Doris SCHERNHAMMER 25 Jan 2023 15 Dec 2023 Antonella ETTORRE 24 Jan 2023 15 Dec 2023 Mr Goncalo FERREIRA-PINTO-MENDES 24 Nov 2022 06 May 2023 Mr Pierluca ARIETTI 19 Nov 2022 18 Nov 2023 Maurizio GUIDI 19 Nov 2022 18 Nov 2023 Ms Sonia Ujupan 24 Sep 2022 23 Sep 2023 Mr Goncalo PINTO MENDES 20 Oct 2021 20 Oct 2022 Doris SCHERNHAMMER 13 May 2021 13 May 2022 Aoife GALLAGHER 11 May 2021 11 May 2022 Ms Sonia Ujupan 05 Mar 2021 05 Mar 2022 Mr Gerd KRAH 27 Feb 2020 27 Feb 2021 Ms Sonia Ujupan 05 Feb 2020 05 Feb 2021 Aoife GALLAGHER 03 Oct 2019 03 Oct 2020 Ms Arantzazu MUGICA GOICOECHEA 30 Mar 2019 01 Apr 2020 Ms Sonia Ujupan 28 Nov 2018 19 Nov 2019 Doris SCHERNHAMMER 10 Nov 2018 09 Nov 2019 Mr Davide RUFFO 09 Nov 2018 09 Nov 2019 Aoife GALLAGHER 24 May 2018 24 May 2019 Ms Sonia Ujupan 13 Nov 2017 20 Oct 2018 Doris SCHERNHAMMER 01 Nov 2017 31 Oct 2018 Doris SCHERNHAMMER 22 Nov 2016 01 Nov 2017 Aoife GALLAGHER 22 Nov 2016 19 Nov 2017 Ms Sonia Ujupan 16 Nov 2016 13 Nov 2017 Ms Elisa Irlandese 15 Sep 2016 14 Sep 2017 Mr Olivier ESPEISSE 14 Jan 2016 13 Jan 2017 Doris SCHERNHAMMER 13 Jan 2016 22 Nov 2016 Ms Athanasia Kanli 17 Nov 2015 12 Nov 2016 Aoife GALLAGHER 23 Jul 2015 20 Jul 2016 Doris SCHERNHAMMER 27 Jan 2015 13 Jan 2016 Ms Athanasia Kanli 10 Dec 2014 17 Nov 2015 Mr Alexander Josef ANTON 04 Apr 2013 19 Nov 2013 Mr Hugh Thomas PULLEN 26 Mar 2013 23 Mar 2014 Mr Alexander Josef ANTON 24 Feb 2012 01 Mar 2013 Mr Hugh Thomas PULLEN 24 Feb 2012 01 Mar 2013 Complementary Information
Note: 3 colleagues are full-time engaged in the Brussels office / Elanco, and 1 outside Brussels, and will spend approx 25% - 50% of their time on relevant EU affairs. A few other colleagues whereas spend a fraction of their time (0-5%).
Person in charge of EU relations
Ms Aoife Gallagher (Head European Government Affairs and Brussels office)
Person with legal responsibility
Mr David Ricks (Chairman and CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Eli Lilly and Company is a member of the following associations and bodies: EFPIA, EuropaBio, AmChamEU, Trans-Atlantic Business Council, American European Community Association, Trans-Atlantic Policy Network, ASOP Global, Animal Health Europe, The European Feed Manufacturers Federation(FEFAC), EU40.
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2017 - Dec 2017
Lobbying costs for closed financial year
750,000€
Other financial info
This estimate is calculated according to pro rata staffing and office costs of Eli Lilly and Company staff involved in interest representation towards the European institutions as defined under the Register, based on the proportion of employee time devoted to these activities. In accordance with the Transparency Register Compliance guidelines on financial information, this estimate of costs as a range includes fees paid for outsourced activities (i.e consultancy contract fees). The estimate includes relevant membership fees to the various trade associations and other bodies. The list is included in the membership section of this form.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
None
Other activities
Health Outcomes, Real World Evidence, Pricing, Reimbursement and Access to medicines, European Medicines Agency, European Chemicals Agency, biopharmaceuticals, healthcare, global health, innovation and research, veterinary medicine, business competitiveness, clinical trials transparency, patient advocacy group payments, transfers of value to healthcare professionals and healthcare organisations.
- Meetings
Meetings
18 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 06 Mar 2023 Location Brussels Subject Pharma package Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Kevin Keary (Cabinet member)
Other Lobbyists -
Date 10 Feb 2023 Location Brussels Subject Discussion of upcoming pharmaceutical package; value of predictability (IP), EU pharmaceutical product approval process, competitiveness, unmet medical needs. Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
Other Lobbyists -
Date 07 Sep 2022 Location Brussels Subject Extension of the so-called ‘TRIPS waiver’ mechanism to therapeutics & diagnostics Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Caroline Boeshertz (Cabinet member)
-
Date 22 Jun 2021 Location Brussels Subject Current trade policy issues EU-US trade relations Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Michael Hager (Cabinet member)
- Cristina Rueda Catry (Cabinet member)
-
Date 05 Feb 2020 Location Brussels Subject Discussion on Cancer and Europe's Beating Cancer Plan Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Tove Ernst (Cabinet member)
Other Lobbyists -
Date 06 Sep 2018 Location Brussels Subject Intellectual property incentives framework in the EU, investment and innovation Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
-
Date 06 Sep 2018 Location Brussels Subject eHealth Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Manuel Mateo-Goyet (Cabinet member)
-
Date 06 Sep 2018 Location Brussels Subject Current EU-US Trade relations; China; intellectual property rights Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Maria Asenius (Cabinet member)
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 15 Jun 2016 Location Brussels Subject REACH Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Marika Lautso-Mousnier (Cabinet member)
- Hilde Hardeman (Cabinet member)
-
Date 15 Jun 2016 Location BERL 08/318 Subject Interservice consultation on a substance used for disinfection in pharma processes called Triton X100 Cabinet Cabinet of Commissioner Phil Hogan Portfolio Agriculture & Rural Development Attending - Dermot Ryan (Cabinet member)
-
Date 09 Mar 2016 Location BERL 08/318 Subject Lilly /Elanco footprint and vision / mission / Hunger / Feeding the world/ How it fits with EU exporting its agriculture Cabinet Cabinet of Commissioner Phil Hogan Portfolio Agriculture & Rural Development Attending - Dermot Ryan (Cabinet member)
-
Date 03 Mar 2015 Location Brussels Subject Animal Health and Welfare, Food Security Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Marco Valletta (Cabinet member)
-
Date 06 Feb 2015 Location Brussels Subject Access to innovative medicine Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 21 Jan 2015 Location Brussels Subject Intro meeting Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
-
Date 03 Dec 2014 Location BERL 08/318 Subject Sustainable agriculture contributing to economic growth Cabinet Cabinet of Commissioner Phil Hogan Portfolio Agriculture & Rural Development Attending - Dermot Ryan (Cabinet member)
-
Date 02 Dec 2014 Location Brussels Subject Life sciences contribution to growth and jobs Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Heidi Jern (Cabinet member)
- Meetings